UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$440M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$390M |
| 3 |
CRH
CRH
|
+$275M |
| 4 |
Advanced Micro Devices
AMD
|
+$228M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$538M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$473M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$397M |
| 4 |
Microsoft
MSFT
|
+$366M |
| 5 |
UnitedHealth
UNH
|
+$312M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.43% |
| 2 | Financials | 6.7% |
| 3 | Healthcare | 6.28% |
| 4 | Consumer Discretionary | 5.01% |
| 5 | Industrials | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5076
iShares MSCI Indonesia ETF
EIDO
$489M
| $290K | ﹤0.01% |
13,039
-486
| -4% | -$11.2K |
|
5077
SmartFinancial
SMBK
$900M
| $290K | ﹤0.01% |
13,560
-705
| -5% | -$16.3K |
|
5078
Peapack-Gladstone Financial
PGC
$822M
| $289K | ﹤0.01% |
11,283
-409
| -3% | -$11.3K |
|
5079
Cellebrite
CLBT
$2.77B
| $289K | ﹤0.01% |
37,827
+31,595
| +507% | +$237K |
|
5080
BrightView Holdings
BV
$1.1B
| $289K | ﹤0.01% |
37,272
+10,366
| +39% | +$82.8K |
|
5081
Amneal Pharmaceuticals
AMRX
$6.17B
| $289K | ﹤0.01% |
68,418
+56,529
| +475% | +$211K |
|
|
EMTL
5082
DELISTED
State Street DoubleLine Emerging Markets Fixed Income ETF
EMTL
| $289K | ﹤0.01% |
7,195
-145
| -2% | -$5.91K |
|
5083
Marten Transport
MRTN
$1.23B
| $288K | ﹤0.01% |
14,611
-37,802
| -72% | -$799K |
|
5084
VanEck Vietnam ETF
VNM
$497M
| $288K | ﹤0.01% |
21,265
+12,076
| +131% | +$176K |
|
5085
Hope Bancorp
HOPE
$1.84B
| $288K | ﹤0.01% |
32,519
-1,275
| -4% | -$12.2K |
|
5086
PUT
Syndax Pharmaceuticals
SNDX
$1.74B
| $287K | ﹤0.01% |
+19,800
| New | +$375K |
|
5087
Lyell Immunopharma
LYEL
$340M
| $287K | ﹤0.01% |
9,754
+2,095
| +27% | +$99.5K |
|
5088
Pennant Group
PNTG
$1.37B
| $287K | ﹤0.01% |
25,747
+4,527
| +21% | +$52.4K |
|
5089
Mesa Laboratories
MLAB
$600M
| $287K | ﹤0.01% |
2,727
-3,281
| -55% | -$420K |
|
|
CMBT
5090
CMB.TECH NV
CMBT
$5.01B
| $286K | ﹤0.01% |
17,409
-74,134
| -81% | -$1.22M |
|
5091
ProShares UltraPro Short QQQ
SQQQ
$1.69B
| $286K | ﹤0.01% |
559
-1,303
| -70% | -$611K |
|
5092
CALL
Upstart Holdings
UPST
$2.96B
| $285K | ﹤0.01% |
+10,000
| New | +$402K |
|
5093
Dream Finders Homes
DFH
$1.39B
| $285K | ﹤0.01% |
12,802
-4,446
| -26% | -$115K |
|
5094
ARK Space & Defense Innovation ETF
ARKX
$862M
| $284K | ﹤0.01% |
20,639
+8,379
| +68% | +$122K |
|
5095
ProShares UltraPro Dow 30
UDOW
$926M
| $284K | ﹤0.01% |
10,576
-17,354
| -62% | -$524K |
|
|
DENN
5096
DELISTED
Denny's
DENN
| $284K | ﹤0.01% |
33,553
-6,162
| -16% | -$62.4K |
|
|
SA
5097
Seabridge Gold
SA
$3.61B
| $284K | ﹤0.01% |
26,932
-9,441
| -26% | -$112K |
|
5098
Sprott Physical Gold
PHYS
$15.8B
| $284K | ﹤0.01% |
19,837
+15,333
| +340% | +$230K |
|
5099
Willdan Group
WLDN
$1.33B
| $284K | ﹤0.01% |
13,903
+228
| +2% | +$4.83K |
|
5100
Weatherford International
WFRD
$6.79B
| $284K | ﹤0.01% |
3,143
-57,759
| -95% | -$4.88M |
|
Similar funds
UBS Group's Q3 2023 Portfolio in Review
As of Q3 2023, UBS Group held 10,416 positions worth $290B, down 2% from $296B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q3 2023 filing shows 1,615 new, 3,254 increased, 4,100 reduced and 999 closed positions. Its largest new stake was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M. The largest sale was NVIDIA, an estimated $538M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2023 buy was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M.
- UBS Group added most to Invesco QQQ Trust in Q3 2023, an estimated $440M increase.
- UBS Group's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $538M.
- UBS Group fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $245M.
- UBS Group's ten largest holdings make up 15% of its $290B portfolio in Q3 2023.
- UBS Group opened 1,615 new positions and closed 999 in Q3 2023.
- UBS Group's portfolio value fell 2% quarter-over-quarter to $290B.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.